Jeff Yass’s Regencell Bioscience RGC Stock Holding History

Jeff Yass’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	+23,129	New	+$555K	﹤0.01%	12254

Other funds holding RGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

Jeff Yass's RGC Position: Q2 2026 in Review

Jeff Yass opened a new position in Regencell Bioscience (RGC) in Q2 2026: 23,129 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #12254 among its holdings.

35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

Jeff Yass held 23,129 shares of Regencell Bioscience worth $141K as of Q2 2026.
Regencell Bioscience was a new Jeff Yass position in Q2 2026.
Regencell Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12254 holding.
35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.